Long-term outcomes of pulmonary arterial hypertension under specific drug therapy in Eisenmenger syndrome-Reference-Cited by-同舟云学术

Long-term outcomes of pulmonary arterial hypertension under specific drug therapy in Eisenmenger syndrome

Published:2017-04 Issue:4 Volume:36 Page:386-398
ISSN:1053-2498
Container-title:The Journal of Heart and Lung Transplantation
language:en
Short-container-title:The Journal of Heart and Lung Transplantation

Author:

Hascoët Sébastien,Baruteau Alban-Elouen,Humbert Marc,Simonneau Gérald,Jais Xavier,Petit Jérôme,Laux Daniela,Sitbon Olivier,Lambert Virginie,Capderou André

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference29 articles.

1. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt;Wood;Br Med J,1958

2. ESC guidelines for the management of grown-up congenital heart disease (new version 2010);Baumgartner;Eur Heart J,2010

3. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study;Galie;Circulation,2006

4. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study;Galie;Circulation,2006

5. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment algorithm for pulmonary arterial hypertension;European Respiratory Journal;2024-08-29

2. 4D flow cardiac MRI to assess pulmonary blood flow in patients with pulmonary arterial hypertension associated with congenital heart disease;Diagnostic and Interventional Imaging;2024-07

3. Development and Validation of a Nomogram of Persistent Pulmonary Hypertension in Adult Pretricuspid Shunts After Correction;Journal of the American Heart Association;2024-05-07

4. Percutaneous atrial septal defect closure in patients with pulmonary arterial hypertension;European Respiratory Journal;2024-05

5. Risk stratification refinements with inclusion of haemodynamic variables at follow-up in patients with pulmonary arterial hypertension;European Respiratory Journal;2024-04-25